InMed Pharmaceuticals Inc. — Form D
InMed Pharmaceuticals Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-08. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-06-08
- Form: D
- Accession: 0001213900-22-031723
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 1
- Date of first sale: 2022-06-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-448510
Issuer
- Name: InMed Pharmaceuticals Inc.
- CIK: 0001728328
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 815 W. HASTINGS STREET, VANCOUVER, A1, V6C 1B4
- Phone: (604) 669-7207
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Adam J Cutler | Director | Vancouver, A1 |
| Brenda A Edwards | Executive Officer | Vancouver, A1 |
| Michael C Woudenberg | Executive Officer | Vancouver, A1 |
| Nicole J Lemerond | Director | Vancouver, A1 |
| Alexandra DJ Mancini | Executive Officer | Vancouver, A1 |
| Eric C Hsu | Executive Officer | Vancouver, A1 |
| Michael DJ Woudenberg | Executive Officer | Vancouver, A1 |
| Bryan J Baldasare | Director | Vancouver, A1 |
| Eric A Adams | Director | Vancouver, A1 |
| Eric A Adams | Executive Officer | Vancouver, A1 |
| William J Garner | Director | Vancouver, A1 |
| Janet J Grove | Director | Vancouver, A1 |
| Andrew J Hull | Director | Vancouver, A1 |
| Sarah A Li | Executive Officer | Vancouver, A1 |
| Andrew A Hull | Director | Vancouver, A1 |
| Catherine A Sazdanoff | Director | Vancouver, A1 |
| Adam A Cutler | Director | Vancouver, A1 |
| Bruce S Colwill | Executive Officer | Vancouver, A1 |
| Jeff J Charpentier | Executive Officer | Vancouver, A1 |
| Sazzad J Hossain | Executive Officer | Vancouver, A1 |
| Martin A Bott | Director | Vancouver, A1 |
Other filings by this issuer (4)
More